Dhoot Transmission and Molbio Diagnostics IPOs See Strong Debut with Premium Listings Shares of Dhoot Transmission and Molbio Diagnostics made a notable debut on the stock exchanges, with both companies listing at prices significantly higher than their initial public offering (IPO) prices. Dhoot Transmission's shares opened at Rs 1,200 on the BSE, marking a 37.77 per cent premium over the IPO price of Rs 871 per share. On the National Stock Exchange (NSE), the stock debuted at Rs 1193.80, a 37.06 per cent increase from the issue price. Molbio Diagnostics shares listed at Rs 980 on both the BSE and NSE, reflecting a 21.44 per cent premium over the IPO price of Rs 807. Both stocks are now available for trading, with the BSE confirming their listing under the 'B' Group of Securities. The IPOs received strong investor demand, with Dhoot Transmission's shares attracting 74.21 times subscription on the final day of the share sale. Molbio Diagnostics, meanwhile, saw a subscription rate of 70.26 times. Ahead of the listing, grey market premiums (GMP) indicated further upside potential. Molbio Diagnostics' unlisted shares were trading at a GMP of Rs 120, suggesting an expected listing price of around Rs 927, which would represent a 14.87 per cent premium over the IPO price. For Dhoot Transmission, the GMP stood at Rs 258, implying a projected listing price of Rs 1129, a 29.62 per cent premium over the issue price. The IPOs also reflected robust fundraising efforts. Molbio Diagnostics, a Goa-based point-of-care diagnostics company, raised Rs 281.5 crore from anchor investors before its public offering. The company is backed by major investors such as Temasek and Motilal Oswal Private Equity. Dhoot Transmission's Rs 3,067-crore IPO attracted bids for 1.#bse #nse #goa #dhoot_transmission #molbio_diagnostics
Molbio Diagnostics Shares Debut at 21% Premium Over IPO Price on BSE and NSE Molbio Diagnostics shares made a strong debut on the stock exchanges, listing at a 21% premium over their initial public offering (IPO) price on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The stock opened at Rs 980 per share on both exchanges, marking a 21.44% increase from the IPO price of Rs 807. This performance exceeded grey market expectations, which had anticipated a listing premium of around 15%. The Rs 939.70 crore IPO was priced at Rs 807 per share, comprising a fresh issue of 25 lakh shares valued at Rs 200 crore and an offer for sale (OFS) of 92 lakh shares worth Rs 739.70 crore. Kotak Mahindra Capital Company served as the book-running lead manager, while KFin Technologies Ltd. acted as the registrar. The company plans to utilize the IPO proceeds to expand its infrastructure and enhance its research and manufacturing capabilities. A significant portion of the funds, approximately Rs 125.12 crore, is allocated for capital expenditure, including the development of a research and development facility, a Centre of Excellence, and related office infrastructure. Another Rs 80.81 crore is earmarked for plant, machinery, and equipment upgrades at its manufacturing facilities in Goa and Visakhapatnam. The remaining proceeds will be used for general corporate purposes, with an estimated total utilization of Rs 205.93 crore from the IPO. Established in October 2000, Molbio Diagnostics Ltd. is a global molecular diagnostics company specializing in the development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases.#national_stock_exchange #bombay_stock_exchange #kfin_technologies_ltd #molbio_diagnostics #kotak_mahindra_capital_company
Five Indian Companies Set to Raise Over Rs 7,400 Crore in Upcoming IPOs Five companies, including e-commerce platform Shiprocket and dairy firm Milky Mist, are set to launch their initial public offerings (IPOs) next week, with a combined issue size expected to exceed Rs 7,400 crore. The IPOs will be opened for subscription on August 10 and 12, marking a significant week for India’s primary market. Dhoot Transmission and Molbio Diagnostics will begin subscriptions on August 10, followed by Milky Mist Dairy Food on August 11. Shiprocket and Behari Lal Engineering will open their public issues on August 12. Together, the five companies aim to raise approximately Rs 7,443 crore, reflecting a surge in corporate fundraising activity. The funds raised from these IPOs are primarily intended for business expansion, capital expenditure, debt repayment, and other corporate purposes. Dhoot Transmission, an auto components manufacturer, has fixed a price band of Rs 829-871 per share for its Rs 3,067-crore IPO. The offering includes a fresh issue of up to Rs 1,400 crore and an offer for sale (OFS) of up to 1.91 crore shares by promoters, including Bain Capital and Mangalam Capital. Molbio Diagnostics, a point-of-care diagnostics firm backed by Temasek and Motilal Oswal Private Equity, has set a price band of Rs 768-807 per share for its Rs 904-940 crore IPO. The issue comprises a fresh issue of up to Rs 200 crore and an OFS of up to 91.66 lakh shares. The International Finance Corporation (IFC), a private-sector investment arm of the World Bank Group, has returned to India’s mainboard IPO market by investing Rs 20 crore as an anchor investor in Goa-based Molbio Diagnostics.#dhoot_transmission #shiprocket #milky_mist_dairy_food #molbio_diagnostics #behari_lal_engineering
